UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046589
Receipt number R000053146
Scientific Title Examination of the effectiveness of the jaw elevation device in airway management during transcatheter aortic valve replacement performed with sedation and local anesthesia.
Date of disclosure of the study information 2022/01/08
Last modified on 2022/01/08 12:41:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the effectiveness of the jaw elevation device in airway management during transcatheter aortic valve replacement performed with sedation and local anesthesia.

Acronym

Examination of the effectiveness of the jaw elevation device in airway management during transcatheter aortic valve replacement performed with sedation and local anesthesia.

Scientific Title

Examination of the effectiveness of the jaw elevation device in airway management during transcatheter aortic valve replacement performed with sedation and local anesthesia.

Scientific Title:Acronym

Examination of the effectiveness of the jaw elevation device in airway management during transcatheter aortic valve replacement performed with sedation and local anesthesia.

Region

Japan


Condition

Condition

Valvular disease for indication of transcatheter aortic valve replacement

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Most patients undergoing transcatheter aortic valve implantation (TAVI) are elderly with severe aortic stenosis, and the 30-day mortality rate is significantly lower with sedation /local anesthesia than with general anesthesia management. With sedation and local anesthesia, airway narrowing and obstruction due to intraoperative glossoptosis frequently occur. The Jaw Elevation Device (JED) is a non-invasive device that prevents airway narrowing in medical procedures performed under spontaneous breathing and sedation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The subjects were TAVI cases performed by sedation and local anesthesia at our facility. We defined the time when patients entered the operating room and were in the supine position as T0. We defined the time at when dexmedetomidine and propofol were administered and sedation was achieved without movement even with strong pinching as T1. Next, we defined the time when the JED was attached as T2. X-ray images of the head and neck were taken at T0, T1, and T2, and we measured the distance from the soft palate to the posterior pharyngeal wall (AW1) and the distance from the epiglottis to the posterior pharyngeal wall (AW2). We calculated the ratio of AW1 and AW2 in T1 to T0 and the ratio of AW1 and AW2 in T2 to T0, and determined the effect of JED on preventing airway obstruction.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Jaw Elevation Device:JED

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

TAVI cases performed by sedation and local anesthesia at our facility.

Key exclusion criteria

Patients with a history of cervical spondylosis.Patients who refused to participate.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hisanari
Middle name
Last name Ishii

Organization

Tenri Hospital

Division name

Department of Anesthesiology

Zip code

632-8552

Address

200 Mishima-cho, Tenri, Nara 632-8552, Japan

TEL

0743-63-5611

Email

hisanari@tenriyorozu.jp


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Mishima

Organization

Tenri Hospital

Division name

Department of Anesthesiology

Zip code

632-8552

Address

200 Mishima-cho, Tenri, Nara 632-8552, Japan

TEL

0743-63-5611

Homepage URL


Email

hiroki.mishima@ompu.ac.jp


Sponsor or person

Institute

Tenri Hospital

Institute

Department

Personal name



Funding Source

Organization

Tenri Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tenri Hospital

Address

200 Mishima-cho, Tenri, Nara 632-8552, Japan

Tel

0743-63-5611

Email

chiken@tenriyorozu.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

No.1239

Org. issuing International ID_1

Tenri Hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2021 Year 12 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 08 Day

Last modified on

2022 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053146


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name